706 research outputs found

    Nanohybrid biosensor based on mussel-inspired electro-cross-linking of tannic acid capped gold nanoparticles and enzymes

    Get PDF
    Complementary tools to classical analytical methods, enzymatic biosensors are widely applied in medical diagnosis due to their high sensitivity, potential selectivity, and their possibility of miniaturization/automation. Among the different protocols of enzyme immobilization, the covalent binding and cross-linking of enzymes ensure the great stability of the developed biosensor. Obtained manually by drop-casting using a specific cross-linker, this immobilization process is not suitable for the specific functionalization of a single electrode out of a microelectrode array. In the present work, we developed a nanohybrid enzymatic biosensor with high sensitivity by a mussel-inspired electro-cross-linking process using a cheap and abundant natural molecule (tannic acid, TA), gold salt, and native enzymes. Based on the use of a cheap natural compound and gold salt, this electro-cross-linking process based on catechol/amine reaction (i) is versatile, likely to be applied on any kind of enzymes, (ii) does not require the synthesis of a specific cross-linker, (ii) gives enzymatic biosensors with high and very stable sensitivity over two weeks upon storage at room temperature and (iv) is temporally and spatially controlled, allowing the specific functionalization of a single electrode out of a microelectrode array. Besides the development of microbiosensors, this process can also be used for the design of enzymatic biofuel cells

    “Quem ensina também aprende” : a formação pela prática de professores primários na província do Paraná

    Full text link

    Chiral edge current in nematic cell monolayers

    Get PDF
    Collectively migrating cells in living organisms are often guided by their local environment, including physical barriers and internal interfaces. Well-controlled in vitro experiments have shown that, when confined in adhesive stripes, monolayers of moderately active spindle-shaped cells self-organize at well-defined angle to the stripes' longitudinal direction and spontaneously give rise to a simple shear flow, where the average cellular orientation smoothly varies across the system. However, the impact of physical boundaries on highly active, chaotic, multicellular systems is currently unknown, despite its potential relevance. In this work, we show that human fibrosarcoma cells (HT1080) close to an interface exhibit a spontaneous edge current with broken left-right symmetry, while in the bulk the cell flow remains chaotic. These localized edge currents result from an interplay between nematic order, microscopic chirality, and topological defects. Using a combination of in vitro experiments, numerical simulations, and theoretical work, we demonstrate the presence of a self-organized layer of thorn 1/2 defects anchored at the boundary and oriented at a well-defined angle close to, but smaller than, 90 degrees with respect to the boundary direction. These self-organized defects act as local sources of chiral active stress generating the directed edge flows. Our work therefore highlights the impact of topology on the emergence of collective cell flows at boundaries. It also demonstrates the role of chirality in the emergence of edge flows. Since chirality and boundaries are common properties of multicellular systems, this work suggests a new possible mechanism for collective cellular flows.Theoretical Physic

    Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females

    Get PDF
    <p>Objectives: Epidemiological evidence for associations of Anti-Müllerian hormone (AMH) with cardiometabolic risk factors is lacking. Existing evidence comes from small studies in select adult populations, and findings are conflicting. We aimed to assess whether AMH is associated with cardiometabolic risk factors in a general population of adolescent females.</p> <p>Methods: AMH, fasting insulin, glucose, HDLc, LDLc, triglycerides and C-reactive protein (CRP) were measured at a mean age 15.5 years in 1,308 female participants in the Avon Longitudinal Study of Parents and Children (ALSPAC). Multivariable linear regression was used to examine associations of AMH with these cardiometabolic outcomes.</p> <p>Results: AMH values ranged from 0.16–35.84 ng/ml and median AMH was 3.57 ng/ml (IQR: 2.41, 5.49). For females classified as post-pubertal (n = 848) at the time of assessment median (IQR) AMH was 3.81 ng/ml (2.55, 5.82) compared with 3.25 ng/ml (2.23, 5.05) in those classed as early pubertal (n = 460, P≤0.001). After adjusting for birth weight, gestational age, pubertal stage, age, ethnicity, socioeconomic position, adiposity and use of hormonal contraceptives, there were no associations with any of the cardiometabolic outcomes. For example fasting insulin changed by 0% per doubling of AMH (95%CI: −3%,+2%) p = 0.70, with identical results if HOMA-IR was used. Results were similar after additional adjustment for smoking, physical activity and age at menarche, after exclusion of 3% of females with the highest AMH values, after excluding those that had not started menarche and after excluding those using hormonal contraceptives.</p> <p>Conclusion: Our results suggest that in healthy adolescent females, AMH is not associated with cardiometabolic risk factors.</p&gt

    The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases

    Get PDF
    Background: The intent of this pooled analysis as part of the German society for radiation oncology (DEGRO)stereotactic body radiotherapy (SBRT) initiative was to analyze the patterns of care of SBRT for liver oligometastases and to derive factors influencing treated metastases control and overall survival in a large patient cohort. Methods: From 17 German and Swiss centers, data on all patients treated for liver oligometastases with SBRT since its introduction in 1997 has been collected and entered into a centralized database. In addition to patient and tumor characteristics, data on immobilization, image guidance and motion management as well as dose prescription and fractionation has been gathered. Besides dose response and survival statistics, time trends of the aforementioned variables have been investigated. Results: In total, 474 patients with 623 liver oligometastases (median 1 lesion/patient; range 1–4) have been collected from 1997 until 2015. Predominant histologies were colorectal cancer (n= 213 pts.; 300 lesions) and breast cancer (n= 57; 81 lesions). All centers employed an SBRT specific setup. Initially, stereotactic coordinates and CT simulation were used for treatment set-up (55%), but eventually were replaced by CBCT guidance (28%) or more recently robotic tracking (17%). High variance in fraction (fx) number (median 1 fx; range 1–13) and dose per fraction (median: 18.5 Gy; range 3–37.5 Gy) was observed, although median BED remained consistently high after an initial learning curve. Median follow-up time was 15 months; median overall survival after SBRT was 24 months. One- and 2-year treated metastases control rate of treated lesions was 77% and 64%; if maximum isocenter biological equivalent dose (BED) was greater than 150 Gy EQD2Gy, it increased to 83% and 70%, respectively. Besides radiation dose colorectal and breast histology and motion management methods were associated with improved treated metastases control

    Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose.

    Get PDF
    Dose, fractionation, normalization and the dose profile inside the target volume vary substantially in pulmonary stereotactic body radiotherapy (SBRT) between different institutions and SBRT technologies. Published planning studies have shown large variations of the mean dose in planning target volume (PTV) and gross tumor volume (GTV) or internal target volume (ITV) when dose prescription is performed to the PTV covering isodose. This planning study investigated whether dose prescription to the mean dose of the ITV improves consistency in pulmonary SBRT dose distributions. This was a multi-institutional planning study by the German Society of Radiation Oncology (DEGRO) working group Radiosurgery and Stereotactic Radiotherapy. CT images and structures of ITV, PTV and all relevant organs at risk (OAR) for two patients with early stage non-small cell lung cancer (NSCLC) were distributed to all participating institutions. Each institute created a treatment plan with the technique commonly used in the institute for lung SBRT. The specified dose fractionation was 3 × 21.5 Gy normalized to the mean ITV dose. Additional dose objectives for target volumes and OAR were provided. In all, 52 plans from 25 institutions were included in this analysis: 8 robotic radiosurgery (RRS), 34 intensity-modulated (MOD), and 10 3D-conformal (3D) radiation therapy plans. The distribution of the mean dose in the PTV did not differ significantly between the two patients (median 56.9 Gy vs 56.6 Gy). There was only a small difference between the techniques, with RRS having the lowest mean PTV dose with a median of 55.9 Gy followed by MOD plans with 56.7 Gy and 3D plans with 57.4 Gy having the highest. For the different organs at risk no significant difference between the techniques could be found. This planning study pointed out that multiparameter dose prescription including normalization on the mean ITV dose in combination with detailed objectives for the PTV and ITV achieve consistent dose distributions for peripheral lung tumors in combination with an ITV concept between different delivery techniques and across institutions
    corecore